{"id":2286,"date":"2025-01-06T14:56:00","date_gmt":"2025-01-06T11:56:00","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=2286"},"modified":"2025-03-07T15:30:18","modified_gmt":"2025-03-07T12:30:18","slug":"santhera-enters-into-supply-and-distribution-agreement-for-agamree-vamorolone-with-clinigen-group","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/pt\/santhera-enters-into-supply-and-distribution-agreement-for-agamree-vamorolone-with-clinigen-group\/","title":{"rendered":"Santhera celebra acordo de fornecimento e distribui\u00e7\u00e3o de AGAMREE (Vamorolone) com Clinigen Group"},"content":{"rendered":"<p class=\"wp-block-paragraph\">A Santhera Pharmaceuticals anuncia a assinatura de um acordo exclusivo com o Clinigen Group para gerenciar o fornecimento e a distribui\u00e7\u00e3o do AGAMREE\u00ae (vamorolone) em pa\u00edses onde o produto n\u00e3o est\u00e1 dispon\u00edvel comercialmente.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A Santhera Pharmaceuticals e a Clinigen Group anunciam que assinaram um Contrato de Fornecimento e Distribui\u00e7\u00e3o do AGAMREE em pa\u00edses onde o produto atualmente n\u00e3o pode ser obtido comercialmente pela Santhera ou por um de seus atuais parceiros de distribui\u00e7\u00e3o.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">O acordo permitir\u00e1 o acesso ao AGAMREE caso a caso para pacientes com distrofia muscular de Duchenne (DMD) em situa\u00e7\u00f5es em que o m\u00e9dico respons\u00e1vel pelo tratamento considere que n\u00e3o h\u00e1 alternativas adequadas e onde as regulamenta\u00e7\u00f5es o permitam. Este acordo permite que a Santhera receba a maior parte da receita gerada pelo fornecimento do produto nesses pa\u00edses adicionais.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.santhera.com\/assets\/files\/press-releases\/2025-01-06-Santhera_Clinigen_e-FINAL.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Ler mais<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Santhera Pharmaceuticals announces the signing of an exclusive agreement with Clinigen Group to manage the supply and distribution of AGAMREE\u00ae (vamorolone) in countries where the product is not otherwise commercially available. Santhera Pharmaceuticals and Clinigen Group announce that they have signed a Supply and Distribution Agreement for AGAMREE in countries where the product can currently [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2287,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[281],"tags":[42,111,41,43],"class_list":["post-2286","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","tag-agamree","tag-clinigen-group","tag-santhera","tag-vamorolone"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/posts\/2286","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/comments?post=2286"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/posts\/2286\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/media\/2287"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/media?parent=2286"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/categories?post=2286"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/tags?post=2286"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}